AwardedRomaniaGoodsFramework agreementRON 22,083,500
acord cadru de furnizare medicamente din grupa ; "antineoplazice si imunomodulatoare- Pembrolizumabum conc pt sol perf 25mg/ml - "
- Published
- Published 30 January 2026
- Deadline
- Closed 5 March 2026
Overview
Mures County Hospital procured a framework agreement for the supply of Pembrolizumab concentrate for perfusion solution 25mg/ml, an immunomodulatory and antineoplastic medication. The contract was awarded on 25 May 2026 to DR.MAX, FARMEXIM S.A., and Merck Sharp & Dohme Romania for a total value of 7,487,290.88 RON.
Key details
- Country
- Romania
- Status
- Awarded
- Category
- Goods
- Estimated value
- RON 22,083,500
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 30 January 2026
- Deadline
- Closed
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- RON 7,487,291
- Award date
- 25 May 2026
- Contract period
- — → 14 May 2028
- DR.MAX
- FARMEXIM S.A.
- Merck Sharp & Dohme Romania
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
6 July 2026
Contract Award Notice
24 April 2026
Contract Notice
30 January 2026
Contracting authority
SPITALUL CLINIC JUDETEAN MURES
Procuring entityTargu Mures, Romania
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.